Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside test

Am J Perinatol. 2005 Aug;22(6):305-9. doi: 10.1055/s-2005-870895.

Abstract

Phosphorylated insulin-like growth factor binding protein-1 (phIGFBP-1) is secreted by decidual cells and may leak into cervical secretions during detachment of the fetal membrane. The aim of this study was to determine whether a rapid bedside test for phIGFBP-1 predicts preterm birth in women with preterm uterine contractions. This was a prospective study of pregnant women who sought medical care for symptoms of preterm labor. Cervical swabs were assayed for the presence of phIGFBP-1 by a rapid bedside test. Sixty-four patients were enrolled. Eleven of them (17%) delivered preterm (< 35 weeks). phIGFBP-1 in cervical secretions predicted preterm birth with a sensitivity of 72.7%, a specificity of 83.0%, a positive predictive value of 47.0%, and negative predictive value of 93.6%. Positive phIGFBP-1 bedside test in women with preterm uterine contractions may indicate a significant risk for subsequent preterm birth. The absence of phIGBP-1 is a reassuring sign that the likelihood of preterm birth is low.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Biomarkers / metabolism
  • Cervix Uteri / metabolism*
  • Female
  • Gestational Age
  • Humans
  • Insulin-Like Growth Factor Binding Protein 1 / metabolism*
  • Logistic Models
  • Obstetric Labor, Premature / diagnosis*
  • Obstetric Labor, Premature / metabolism*
  • Odds Ratio
  • Point-of-Care Systems*
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy, Multiple / metabolism
  • Prospective Studies

Substances

  • Biomarkers
  • Insulin-Like Growth Factor Binding Protein 1